Patent · US Active

Compounds and methods for EP300 or CBP modulation and indications therefor

US11446287B2 · kind B2 · utility

1Cited by

86References

37Claims

0Family size

Assignee

Opna Immuno-Oncology SA · CH

Inventors

Wayne Spevak · Berkeley, US
John Buell · San Francisco, US
Zuojun Guo · Pasadena, US
Hiroaki Inagaki · Tokyo, JP
Yongil Jin · Emeryville, US
Phuongly Pham · Hayward, US
Songyuan Shi · Fremont, US
Jack Walleshauser · Berkeley, US
Jeffrey Wu · San Francisco, US
Guoxian Wu · Palo Alto, US
Chao Zhang · 安丰镇, CN
Jiazhong Zhang · Foster City, US
Ying Zhang · Beijing, CN

Key dates

Filing date	Apr 8, 2020
Grant date	Sep 20, 2022
Priority date	—
Expiry date	Apr 8, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds of Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.